1
|
Raj G, Vasantha AP, Sreekumar VD, Beena AV, Dommeti VKK, Perozhy H, Jose AT, Khurana S, Varghese R. Bimetallic DNAsome Decorated with G 4-DNA as a Nanozyme for Targeted and Enhanced Chemo/Chemodynamic Cancer Therapy. Adv Healthc Mater 2024:e2400256. [PMID: 38669674 DOI: 10.1002/adhm.202400256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2024] [Revised: 04/23/2024] [Indexed: 04/28/2024]
Abstract
Cancer is indisputably one of the major threats to mankind and hence the design of new approaches for the improvement of existing therapeutic strategies is always wanted. Herein, the design of a TME-responsive, DNA-based CDT nanoagent with dual Fenton reaction centers for targeted cancer therapy is reported. Self-assembly of DNA amphiphile containing copper complex as the hydrophobic Fenton reaction center results in the formation of CDT-active DNAsome with Cu2+-based Fenton catalytic site as the hydrophobic core and hydrophilic ssDNA protrude on the surface. DNA-based surface addressability of the DNAsome is then used for the integration of second Fenton reaction center, which is a peroxidase-mimicking DNAzyme noncovalently loaded with Hemin and Doxorubicin, via DNA hybridization to give a CDT agent having dual Fenton reaction centres. Targeted internalization of the CDT nanoagent and selective generation of •OH inside HeLa cell are also shown. Excellent therapeutic efficiency is observed for the CDT nanoagent both in vitro and in vivo and the enhanced efficacy is attributed to the combined and synergetic action of CDT and chemotherapy. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Gowtham Raj
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| | - Anu P Vasantha
- School of Biology, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| | - Vasudev D Sreekumar
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| | - Athul V Beena
- School of Biology, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| | - Viswa Kalyan Kumar Dommeti
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| | - Harsha Perozhy
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| | - Alwin T Jose
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| | - Satish Khurana
- School of Biology, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| | - Reji Varghese
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, Kerala, 695551, India
| |
Collapse
|
2
|
Raj G, Vasudev DS, Christopher S, Babulal A, Harsha P, Ram S, Tiwari M, Sauer M, Varghese R. Multifunctional siRNA/ferrocene/cyclodextrin nanoparticles for enhanced chemodynamic cancer therapy. Nanoscale 2024; 16:3755-3763. [PMID: 38299362 DOI: 10.1039/d3nr06071c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2024]
Abstract
The therapeutic outcome of chemodynamic therapy (CDT) is greatly hindered by the presence of oxidative damage repair proteins (MTH1) inside cancer cells. These oxidative damage repair proteins detoxify the action of radicals generated by Fenton or Fenton-like reactions. Hence, it is extremely important to develop a simple strategy for the downregulation of MTH1 protein inside cancer cells along with the delivery of metal ions into cancer cells. A one-pot host-guest supramolecular approach for the codelivery of MTH1 siRNA and metal ions into a cancer cell is reported. Our approach involves the fabrication of an inclusion complex between cationic β-cyclodextrin and a ferrocene prodrug, which spontaneously undergoes amphiphilicity-driven self-assembly to form spherical nanoparticles (NPs) having a positively charged surface. The cationic surface of the NPs was then explored for the loading of MTH1 siRNA through electrostatic interactions. Using HeLa cells as a representative example, efficient uptake of the NPs, delivery of MTH1 siRNA and the enhanced CDT of the nanoformulation are demonstrated. This work highlights the potential of the supramolecular approach as a simple yet efficient method for the delivery of siRNA across the cell membrane for enhanced chemodynamic therapy.
Collapse
Affiliation(s)
- Gowtham Raj
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| | - D S Vasudev
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| | - Sarah Christopher
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| | - Anupama Babulal
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| | - P Harsha
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| | - Soumakanya Ram
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| | - Mehul Tiwari
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| | - Markus Sauer
- Department of Biotechnology and Biophysics, Biocenter, Julius Maximilian University of Würzburg, Würzburg, Germany
| | - Reji Varghese
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| |
Collapse
|
3
|
Ravi A, Pathigoolla A, Balan H, Gupta R, Raj G, Varghese R, Sureshan KM. Adamantoid Scaffolds for Multiple Cargo Loading and Cellular Delivery as β-Cyclodextrin Inclusion Complexes. Angew Chem Int Ed Engl 2023; 62:e202307324. [PMID: 37384430 DOI: 10.1002/anie.202307324] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 06/24/2023] [Accepted: 06/29/2023] [Indexed: 07/01/2023]
Abstract
There is huge demand for developing guests that bind β-CD and can conjugate multiple cargos for cellular delivery. We synthesized trioxaadamantane derivatives, which can conjugate up to three cargos per guest. 1 H NMR titration and isothermal titration calorimetry revealed these guests form 1 : 1 inclusion complexes with β-CD with association constants in the order of 103 M-1 . Co-crystallization of β-CD with guests yielded crystals of their 1 : 1 inclusion complexes as determined by single-crystal X-ray diffraction. In all cases, trioxaadamantane core is buried within the hydrophobic cavity of β-CD and three hydroxyl groups are exposed outside. We established biocompatibility using representative candidate G4 and its inclusion complex with β-CD (β-CD⊂G4), by MTT assay using HeLa cells. We incubated HeLa cells with rhodamine-conjugated G4 and established cellular cargo delivery using confocal laser scanning microscopy (CLSM) and fluorescence-activated cell sorting (FACS) analysis. For functional assay, we incubated HeLa cells with β-CD-inclusion complexes of G4-derived prodrugs G6 and G7, containing one and three units of the antitumor drug (S)-(+)-camptothecin, respectively. Cells incubated with β-CD⊂G7 displayed the highest internalization and uniform distribution of camptothecin. β-CD⊂G7 showed higher cytotoxicity than G7, camptothecin, G6 and β-CD⊂G6, affirming the efficiency of adamantoid derivatives in high-density loading and cargo delivery.
Collapse
Affiliation(s)
- Arthi Ravi
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Atchutarao Pathigoolla
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Haripriya Balan
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Ria Gupta
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Gowtham Raj
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Reji Varghese
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Kana M Sureshan
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| |
Collapse
|
4
|
Perumal D, Krishna J, Harikrishnan KS, Raj G, Kalathil J, Saji M, M K, Varghese R. 19F NMR ON/OFF nanoparticles: a universal approach for the specific detection of DNA-binding cancer biomarkers. Nanoscale 2023; 15:8972-8977. [PMID: 37132404 DOI: 10.1039/d3nr01175e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
A supramolecular approach for the design of assembly-disassembly-driven 19F ON/OFF nanoparticles, triggered by specific molecular recognition, for the detection of DNA binding cancer biomarkers is reported. The key to our design strategy is the characteristic 19F NMR signal of the probe, which completely vanishes in the aggregated state due to the shortening of T2 relaxation. However, molecular recognition of DNA by the cancer biomarkers through specific molecular recognition results in the disassembly of the nanoparticles, which causes the restoration of the characteristic 19F signal of the probe. The universal nature of the approach is demonstrated through the selective detection of various cancer biomarkers including miRNA, ATP, thrombin, and telomerase.
Collapse
Affiliation(s)
- Devanathan Perumal
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum 695541, Kerala, India.
| | - Jithu Krishna
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum 695541, Kerala, India.
| | - Kaloor S Harikrishnan
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum 695541, Kerala, India.
| | - Gowtham Raj
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum 695541, Kerala, India.
| | - Jemshiya Kalathil
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum 695541, Kerala, India.
| | - Minu Saji
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum 695541, Kerala, India.
| | - Kavyasree M
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum 695541, Kerala, India.
| | - Reji Varghese
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum 695541, Kerala, India.
| |
Collapse
|
5
|
Perumal D, Kalathil J, Krishna J, Raj G, Harikrishnan KS, Uthpala ML, Gupta R, Varghese R. Supramolecular grafting of stimuli-responsive, carrier-free, self-deliverable nanoparticles of camptothecin and antisense DNA for combination cancer therapy. NEW J CHEM 2022. [DOI: 10.1039/d2nj01952c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A supramolecular approach for the crafting of self-deliverable nanoparticles of antisense DNA and camptothecin for combination cancer therapy is reported.
Collapse
Affiliation(s)
- Devanathan Perumal
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum, 695551, Kerala, India
| | - Jemshiya Kalathil
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum, 695551, Kerala, India
| | - Jithu Krishna
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum, 695551, Kerala, India
| | - Gowtham Raj
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum, 695551, Kerala, India
| | - Kaloor S. Harikrishnan
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum, 695551, Kerala, India
| | - M. L. Uthpala
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum, 695551, Kerala, India
| | - Ria Gupta
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum, 695551, Kerala, India
| | - Reji Varghese
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum, 695551, Kerala, India
| |
Collapse
|
6
|
Harikrishnan KS, Krishnan N, Kumar NM, Krishna A, Raj G, Perumal D, Kalathil J, Krishna J, Varghese R. Galactose Grafted Two-Dimensional Nanosheets as a Scaffold for the In Situ Synthesis of Silver Nanoparticles: A Potential Catalyst for the Reduction of Nitroaromatics. Chemistry 2021; 27:14100-14107. [PMID: 34398494 DOI: 10.1002/chem.202102421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Indexed: 11/06/2022]
Abstract
Two major hurdles in NP-based catalysis are the aggregation of the NPs and their recycling. Immobilization of NPs onto a 2D support is the most promising strategy to overcome these difficulties. Herein, amphiphilicity-driven self-assembly of galactose-hexaphenylbenzene-based amphiphiles into galactose-decorated 2D nanosheet is reported. The extremely dense decoration of reducing sugar on the surface of the sheets is used for the in situ synthesis and immobilization of ultrafine catalytically active AgNPs by using Tollens' reaction. The potential of the system as a catalyst for the reduction of various nitroaromatics is demonstrated. Enhanced catalytic activity is observed for the immobilized AgNPs when compared to the corresponding discrete AgNPs. Recovery of the catalytic system from the reaction mixture by ultrafiltration and its subsequent recycling for several cycles without dropping its activity is shown. This is the first report demonstrating the in situ synthesis and immobilization of ultrafine AgNPs onto a 2D nanosheet that exhibits excellent catalytic performance for the reduction of nitroaromatics.
Collapse
Affiliation(s)
- Kaloor S Harikrishnan
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| | - Nithiyanandan Krishnan
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| | - Nilima Manoj Kumar
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| | - Anusree Krishna
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| | - Gowtham Raj
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| | - Devanathan Perumal
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| | - Jemshiya Kalathil
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| | - Jithu Krishna
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| | - Reji Varghese
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Thiruvananthapuram, 695551, Kerala, India
| |
Collapse
|
7
|
Perumal D, Golla M, Pillai KS, Raj G, Krishna P K A, Varghese R. Biotin-decorated NIR-absorbing nanosheets for targeted photodynamic cancer therapy. Org Biomol Chem 2021; 19:2804-2810. [PMID: 33720265 DOI: 10.1039/d1ob00002k] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Targeted photodynamic therapy (PDT) is one of the promising approaches for the selective killing of cancerous cells without affecting the normal cells, and hence designing new strategies for targeted PDT is extremely important. Herein we report the design and synthesis of a new class of nanosheets derived from the self-assembly of the iodo-BODIPY-biotin conjugate as a photosensitizer for targeted PDT applications. The nanosheet exhibits a high extinction coefficient in the NIR region, high singlet oxygen efficiency, no toxicity in the dark and cell targeting ligands (biotin) on the surface, which are necessary features required for an ideal photosensitizer. Overexpression of sodium-dependent multivitamin transporters (SMVTs) in HeLa and A549 (biotin receptor positive cell lines) is explored for the selective uptake of the nanophotosensitizer through receptor mediated endocytosis (interaction between biotin and SMVT). Control experiments using a biotin receptor negative cell line (WI-38) are also carried out to confirm that the specific interaction between the SMVTs and biotin is mainly responsible for the selective uptake of the photosensitizer. Efficient killing of cancerous cells is demonstrated upon light irradiation through the generation of singlet oxygen and other reactive oxygen species around the cellular environment.
Collapse
Affiliation(s)
- Devanathan Perumal
- School of Chemistry, Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, Trivandrum-695551, Kerala, India.
| | | | | | | | | | | |
Collapse
|
8
|
Chandrasekharan SV, Krishnan N, Atchimnaidu S, Raj G, P. K. AK, Sagar S, Das S, Varghese R. Blue-emissive two-component supergelator with aggregation-induced enhanced emission. RSC Adv 2021; 11:19856-19863. [PMID: 35479242 PMCID: PMC9033671 DOI: 10.1039/d1ra03751j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2021] [Accepted: 05/28/2021] [Indexed: 11/21/2022] Open
Abstract
Two-component organogels offer several advantages over one-component gels, but their design is highly challenging. Hence, it is extremely important to design new approaches for the crafting of two-component organogels with interesting optical and mechanical properties. Herein, we report the design of a new class of two-component supergelators obtained from the assembly between acid functionalized tetraphenylethylene (TPE)-based dendrons and alkylated melamine. No gelation behaviour is observed for the individual components, but interestingly, remarkable gelation behaviour is observed for their hydrogen-bonded complex. The primary driving force responsible for the gelation is the strong π–π stacking interaction of TPE units. Because of the strong π-stacking of TPEs in the gel state, the C(sp2)–C(sp2) bond rotation of the TPE segment is completely arrested in the gel state, which results in intense fluorescence emission of the gels. Furthermore, excellent elastic response is observed for the gels as evident from their high storage modulus compared to loss modulus values. Our results clearly demonstrate that by the appropriate selection of the molecular components, this approach can be applied for the creation of functional nanomaterials with emergent properties absent in the individual blocks. Design of a novel class of two-component, highly emissive, low molecular weight supergelator is reported.![]()
Collapse
Affiliation(s)
| | - Nithiyanandan Krishnan
- School of Chemistry
- Indian Institute of Science Education and Research (IISER)
- Thiruvananthapuram
- India
| | - Siriki Atchimnaidu
- School of Chemistry
- Indian Institute of Science Education and Research (IISER)
- Thiruvananthapuram
- India
| | - Gowtham Raj
- School of Chemistry
- Indian Institute of Science Education and Research (IISER)
- Thiruvananthapuram
- India
| | - Anusree Krishna P. K.
- School of Chemistry
- Indian Institute of Science Education and Research (IISER)
- Thiruvananthapuram
- India
| | - Soumya Sagar
- School of Chemistry
- Indian Institute of Science Education and Research (IISER)
- Thiruvananthapuram
- India
| | - Suresh Das
- School of Chemistry
- Indian Institute of Science Education and Research (IISER)
- Thiruvananthapuram
- India
| | - Reji Varghese
- School of Chemistry
- Indian Institute of Science Education and Research (IISER)
- Thiruvananthapuram
- India
| |
Collapse
|
9
|
San Miguel Claveria P, Adli E, Amorim LD, An W, Clayton CE, Corde S, Gessner S, Hogan MJ, Joshi C, Kononenko O, Litos M, Lu W, Marsh KA, Mori WB, O'Shea B, Raj G, Storey D, Vafaei-Najafabadi N, White G, Xu X, Yakimenko V. Betatron radiation and emittance growth in plasma wakefield accelerators. Philos Trans A Math Phys Eng Sci 2019; 377:20180173. [PMID: 31230577 PMCID: PMC6602914 DOI: 10.1098/rsta.2018.0173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Accepted: 03/20/2019] [Indexed: 06/09/2023]
Abstract
Beam-driven plasma wakefield acceleration (PWFA) has demonstrated significant progress during the past two decades of research. The new Facility for Advanced Accelerator Experimental Tests (FACET) II, currently under construction, will provide 10 GeV electron beams with unprecedented parameters for the next generation of PWFA experiments. In the context of the FACET II facility, we present simulation results on expected betatron radiation and its potential application to diagnose emittance preservation and hosing instability in the upcoming PWFA experiments. This article is part of the Theo Murphy meeting issue 'Directions in particle beam-driven plasma wakefield acceleration'.
Collapse
Affiliation(s)
- P. San Miguel Claveria
- LOA, ENSTA ParisTech, CNRS, Ecole Polytechnique, Institut Polytechnique de Paris, 91762 Palaiseau, France
| | - E. Adli
- University of Oslo, NO-0316 Oslo, Norway
| | - L. D. Amorim
- Stonybrook University, Stony Brook, NY 11794, USA
| | - W. An
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - C. E. Clayton
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - S. Corde
- LOA, ENSTA ParisTech, CNRS, Ecole Polytechnique, Institut Polytechnique de Paris, 91762 Palaiseau, France
| | | | - M. J. Hogan
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - C. Joshi
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - O. Kononenko
- LOA, ENSTA ParisTech, CNRS, Ecole Polytechnique, Institut Polytechnique de Paris, 91762 Palaiseau, France
| | - M. Litos
- University of Colorado Boulder, Boulder, CO 80309, USA
| | - W. Lu
- Tsinghua University, Beijing 10084, People's Republic of China
| | - K. A. Marsh
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - W. B. Mori
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - B. O'Shea
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - G. Raj
- LOA, ENSTA ParisTech, CNRS, Ecole Polytechnique, Institut Polytechnique de Paris, 91762 Palaiseau, France
| | - D. Storey
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | | | - G. White
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - Xinlu Xu
- University of California Los Angeles, Los Angeles, CA 90095, USA
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - V. Yakimenko
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| |
Collapse
|
10
|
Vafaei-Najafabadi N, Amorim LD, Adli E, An W, Clarke CI, Clayton CE, Corde S, Gessner S, Green SZ, Hogan MJ, Joshi C, Kononenko O, Lindstrøm CA, Litos M, Lu W, Marsh KA, Mori WB, San Miguel Claveria P, O'Shea B, Raj G, Storey D, White G, Xu X, Yakimenko V. Producing multi-coloured bunches through beam-induced ionization injection in plasma wakefield accelerator. Philos Trans A Math Phys Eng Sci 2019; 377:20180184. [PMID: 31230576 PMCID: PMC6602915 DOI: 10.1098/rsta.2018.0184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 03/20/2019] [Indexed: 06/09/2023]
Abstract
This paper discusses the properties of electron beams formed in plasma wakefield accelerators through ionization injection. In particular, the potential for generating a beam composed of co-located multi-colour beamlets is demonstrated in the case where the ionization is initiated by the evolving charge field of the drive beam itself. The physics of the processes of ionization and injection are explored through OSIRIS simulations. Experimental evidence showing similar features are presented from the data obtained in the E217 experiment at the FACET facility of the SLAC National Laboratory. This article is part of the Theo Murphy meeting issue 'Directions in particle beam-driven plasma wakefield acceleration'.
Collapse
Affiliation(s)
| | - L. D. Amorim
- Stony Brook University, Stony Brook, NY 11794, USA
| | - E. Adli
- University of Oslo, Oslo 0316, Norway
| | - W. An
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - C. I. Clarke
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - C. E. Clayton
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - S. Corde
- LOA, ENSTA ParisTech, CNRS, Ecole Polytechnique, Université Paris-Saclay, Palaiseau 91762, France
| | | | - S. Z. Green
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - M. J. Hogan
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - C. Joshi
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - O. Kononenko
- LOA, ENSTA ParisTech, CNRS, Ecole Polytechnique, Université Paris-Saclay, Palaiseau 91762, France
| | | | - M. Litos
- University of Colorado Boulder, Boulder, CO 80309, USA
| | - W. Lu
- Tsinghua University, Beijing 10084, People's Republic of China
| | - K. A. Marsh
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - W. B. Mori
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - P. San Miguel Claveria
- LOA, ENSTA ParisTech, CNRS, Ecole Polytechnique, Université Paris-Saclay, Palaiseau 91762, France
| | - B. O'Shea
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - G. Raj
- LOA, ENSTA ParisTech, CNRS, Ecole Polytechnique, Université Paris-Saclay, Palaiseau 91762, France
| | - D. Storey
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - G. White
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - Xinlu Xu
- University of California Los Angeles, Los Angeles, CA 90095, USA
| | - V. Yakimenko
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| |
Collapse
|
11
|
Viswanadhapalli S, Luo Y, Sareddy GR, Santhamma B, Zhou M, Li M, Pratap UP, Altwegg KA, Li X, Srinivasan U, Ma S, Chang A, Riveros AC, Zhang KY, Dileep KV, Pan X, Murali R, Bajda M, Raj G, Brenner A, Manthati V, Rao M, Tekmal RR, Nair HB, Nickisch KJ, Vadlamudi RK. Abstract P2-06-02: Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p2-06-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Leukemia inhibitory factor (LIF) and its receptor LIFR are over-expressed in multiple solid tumors and play a key role in tumor growth, progression, and resistance to standard anti-cancer treatments. Triple-negative breast cancer (TNBC) lacks targeted therapies and represents a disproportional share of breast cancer (BCa) mortality. TNBC exhibits autocrine stimulation of the LIF/LIFR axis and overexpression of LIF is associated with poorer relapse-free survival in BCa patients. LIF signaling also promotes maintenance of stem cells. Therefore, targeting the LIF/LIFR axis may have therapeutic utility in TNBC.
Methods: We rationally designed a small organic molecule (EC359) that emulates the LIF/LIFR binding site and functions as a LIFR inhibitor from a library of compounds. In silico docking studies were used to identify the putative interaction of the EC359 and LIF/LIFR complex. Direct binding of EC359 to LIFR was confirmed using surface plasmon resonance (SPR) and microscale thermophoresis technique (MST) assays. In vitro activity was tested using Cell-Titer Glo, MTT, invasion, and apoptosis assays. Mechanistic studies were conducted using Western blot, reporter gene assays, and RNA-seq analysis. Xenograft, patient-derived xenograft (PDX), and patient-derived explant (PDEX) models were used for preclinical evaluation and toxicity.
Results: Molecular docking studies showed that EC359 interacts at the LIF/LIFR binding interface. SPR and MST studies confirmed direct interaction of EC359 to LIFR. EC359 reduced the growth of TNBC cells with high potency (IC50 50-100nM) and promoted apoptosis. Further, EC359 treatment reduced invasion and stemness of TNBC cells. EC359 activity is dependent on the expression levels of LIFR and showed little or no activity on TNBC cells that have low levels of LIFR or ER+ve BCa cells. Further, EC359 significantly reduced the viability of cisplatin and taxane-resistant TNBC cells and enhanced the efficacy of HDAC inhibitors. Mechanistic and biochemical studies showed that EC359 interacts with LIFR and effectively blocking LIF/LIFR interactions. EC359 also blocked LIFR interactions with other LIFR ligands such as oncostatin M, ciliary neurotrophic factor, and cardiotrophin-1. EC359 treatment attenuated the activation of LIF/LIFR driven pathways including STAT3, mTOR, AKT, and MAPK. RNA-seq analysis identified regulation of apoptosis as one of the important pathway modulated by EC359. In TNBC xenograft and PDX assays, EC359 significantly reduced tumor progression. Further, using human primary BCa PDEX cultures, we demonstrated that EC359 has the potential to substantially reduce the proliferation of human BCa. Pharmacologically, EC359 exhibited high oral bioavailability and long half-life with a wide therapeutic window.
Conclusions: EC359 is a novel targeted therapeutic agent that inhibits LIF/LIFR oncogenic signaling in TNBC via a unique mechanism of action. EC359 has the distinct pharmacologic advantages of oral bioavailability, in vivo stability, and is associated with minimal systemic side effects. (DOD BCRP grant #BC170312)
Citation Format: Viswanadhapalli S, Luo Y, Sareddy GR, Santhamma B, Zhou M, Li M, Pratap UP, Altwegg KA, Li X, Srinivasan U, Ma S, Chang A, Riveros AC, Zhang KY, Dileep KV, Pan X, Murali R, Bajda M, Raj G, Brenner A, Manthati V, Rao M, Tekmal RR, Nair HB, Nickisch KJ, Vadlamudi RK. Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-06-02.
Collapse
Affiliation(s)
- S Viswanadhapalli
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - Y Luo
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - GR Sareddy
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - B Santhamma
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - M Zhou
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - M Li
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - UP Pratap
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - KA Altwegg
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - X Li
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - U Srinivasan
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - S Ma
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - A Chang
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - AC Riveros
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - KY Zhang
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - KV Dileep
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - X Pan
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - R Murali
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - M Bajda
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - G Raj
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - A Brenner
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - V Manthati
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - M Rao
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - RR Tekmal
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - HB Nair
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - KJ Nickisch
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| | - RK Vadlamudi
- UT Health and Mays Cancer Center, San Antonio; Evestra, Inc., San Antonio; Instituto de Química, Ciudad de, Mexico; RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan; Cidars-Sinai Medical Center, Los Angeles; Jagiellonian University, Cracow, Poland; UT Southwestern, Dallas
| |
Collapse
|
12
|
Raj G, Murugesan. K, John P. CRC7: Designing and Fabrication of Highly Precisive Robotic Arm With 3D Printing Technology for a Congenitally Missing Patient's Hand - A Clinical Case. J Indian Prosthodont Soc 2018; 18:S38. [PMID: 30532460 PMCID: PMC6238516 DOI: 10.4103/0972-4052.244662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Gowtham Raj
- SRM Dental College, Ramapuram, Chennai, India
| | | | - Peter John
- SRM Dental College, Ramapuram, Chennai, India
| |
Collapse
|
13
|
Vieux G, Cipiccia S, Grant DW, Lemos N, Grant P, Ciocarlan C, Ersfeld B, Hur MS, Lepipas P, Manahan GG, Raj G, Reboredo Gil D, Subiel A, Welsh GH, Wiggins SM, Yoffe SR, Farmer JP, Aniculaesei C, Brunetti E, Yang X, Heathcote R, Nersisyan G, Lewis CLS, Pukhov A, Dias JM, Jaroszynski DA. An ultra-high gain and efficient amplifier based on Raman amplification in plasma. Sci Rep 2017; 7:2399. [PMID: 28546551 PMCID: PMC5445100 DOI: 10.1038/s41598-017-01783-4] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Accepted: 03/31/2017] [Indexed: 11/10/2022] Open
Abstract
Raman amplification arising from the excitation of a density echelon in plasma could lead to amplifiers that significantly exceed current power limits of conventional laser media. Here we show that 1-100 J pump pulses can amplify picojoule seed pulses to nearly joule level. The extremely high gain also leads to significant amplification of backscattered radiation from "noise", arising from stochastic plasma fluctuations that competes with externally injected seed pulses, which are amplified to similar levels at the highest pump energies. The pump energy is scattered into the seed at an oblique angle with 14 J sr-1, and net gains of more than eight orders of magnitude. The maximum gain coefficient, of 180 cm-1, exceeds high-power solid-state amplifying media by orders of magnitude. The observation of a minimum of 640 J sr-1 directly backscattered from noise, corresponding to ≈10% of the pump energy in the observation solid angle, implies potential overall efficiencies greater than 10%.
Collapse
Affiliation(s)
- G Vieux
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom.
- Institute of Physics of the ASCR, ELI-Beamlines, Na Slovance 2, 182 21, Prague, Czech Republic.
| | - S Cipiccia
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
- Diamond Light Source, Harwell Science and Innovation Campus, Fermi Ave, Didcot, OX11 0DE, UK
| | - D W Grant
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - N Lemos
- GoLP/Instituto de Plasmas e Fusão Nuclear, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal
- Lawrence Livermore National laboratory, NIF and photon Sciences, 7000, East avenue, Livermore, CA, 94550, USA
| | - P Grant
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - C Ciocarlan
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
- IFIN-HH, National Institute for Physics and Nuclear Engineering, Bucharest, Romania
| | - B Ersfeld
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - M S Hur
- UNIST, Banyeon-ri 100. Ulju-gun, Ulsan, 689-798, South Korea
| | - P Lepipas
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - G G Manahan
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - G Raj
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
- Centre de Physique Théorique, École Polytechnique, 91128, Palaiseau cedex, France
| | - D Reboredo Gil
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - A Subiel
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
- Medical Radiation Science, National Physical Laboratory, Medical Radiation Science, Hampton Road, Teddington, Middlesex, TW11 0LW, UK
| | - G H Welsh
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - S M Wiggins
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - S R Yoffe
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - J P Farmer
- Theoretische Physik I, Heinrich Heine Universität, 40225, Düsseldorf, Germany
| | - C Aniculaesei
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
- Center for Relativistic Laser Science, Institute for Basic Science, Gwangju, 61005, Republic of Korea
| | - E Brunetti
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
| | - X Yang
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom
- Department of Physics, Capital Normal University, Key Lab of Terahertz Optoelectronics, Ministry of Education, and Beijing Advanced Innovation Center for Imaging Technology, Beijing, 100048, China
| | - R Heathcote
- Central Laser Facility, Rutherford Appleton Laboratory, Didcot, OX11 0QX, United Kingdom
| | - G Nersisyan
- Centre for Plasma Physics, School of Mathematics and Physics, Queens University Belfast, Belfast, BT7 1NN, United Kingdom
| | - C L S Lewis
- Centre for Plasma Physics, School of Mathematics and Physics, Queens University Belfast, Belfast, BT7 1NN, United Kingdom
| | - A Pukhov
- Theoretische Physik I, Heinrich Heine Universität, 40225, Düsseldorf, Germany
| | - J M Dias
- GoLP/Instituto de Plasmas e Fusão Nuclear, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal
| | - D A Jaroszynski
- Department of Physics, Scottish Universities Physics Alliance and University of Strathclyde, Department of Physics, Glasgow, G4 0NG, United Kingdom.
| |
Collapse
|
14
|
Raj G, Hüller S. Impact of Laser Beam Speckle Structure on Crossed Beam Energy Transfer via Beam Deflections and Ponderomotive Self-Focusing. Phys Rev Lett 2017; 118:055002. [PMID: 28211711 DOI: 10.1103/physrevlett.118.055002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/21/2016] [Indexed: 05/16/2023]
Abstract
The role of laser speckle structure (hot spots) and its ponderomotive self-focusing (PSF), in crossed beam energy transfer (CBET), of smoothed laser beams is investigated in an inhomogeneous expanding plasma. Numerical simulations using the code harmony in two spatial dimensions, demonstrate how self-focusing of laser hot spots in crossed beams can significantly affect the transfer of energy from one beam to the other in addition to the stimulated Brillouin scattering (SBS) process. It is shown that for sufficiently intense laser beams, when the laser hot spots exceed the criterion for self-focusing in a plasma with flow, the angular spread of transmitted light beams increases considerably with the intensity, which arises in particular, in expanding plasma where significant beam deflection is observed. It is shown for the first time that besides SBS, the contribution of speckle structure, PSF, and deflections of the intense hot spots in multiple speckle beams to CBET, therefore matters.
Collapse
Affiliation(s)
- G Raj
- Centre de Physique Théorique (CPHT), Ecole Polytechnique, CNRS, Université Paris-Saclay, 91128 Palaiseau, France
| | - S Hüller
- Centre de Physique Théorique (CPHT), Ecole Polytechnique, CNRS, Université Paris-Saclay, 91128 Palaiseau, France
| |
Collapse
|
15
|
Affiliation(s)
| | - G Raj
- Department of Radiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Gomtinagar, Lucknow 226010, India
| | - S Singh
- Department of Radiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Gomtinagar, Lucknow 226010, India
| | | | - A K Singh
- From the Department of Neurology and
| | | |
Collapse
|
16
|
Raj G, Chandrasekaran M, Krishnamoorthy S, Venkatesalu V. Antibacterial activity of different solvent extracts of Caulerpa chemnitzia (Esper) J.V. Lamououx, from Mandapam, Gulf of Mannar Southeast Coast, Tamilnadu, India. ACTA ACUST UNITED AC 2015. [DOI: 10.5455/jmhe.2015-07-09] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
17
|
Raj G, Bell HK. A multi-centre audit on genital Lichen sclerosus in the North West of England. J Eur Acad Dermatol Venereol 2013; 28:963-6. [DOI: 10.1111/jdv.12173] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2013] [Accepted: 04/02/2013] [Indexed: 11/26/2022]
Affiliation(s)
- G. Raj
- Lanarkshire centre for Dermatology; Glasgow UK
| | - H. K. Bell
- Department of Dermatology; Royal Liverpool and Broadgreen University Hospital Trust; Liverpool UK
| |
Collapse
|
18
|
Raj G, Gordon J, Logan T, Hall D, Deluca A, Giordano A, Khalili K. Characterization of glioma-cells derived from human polyomavirus-induced brain-tumors in hamsters. Int J Oncol 2012; 7:801-8. [PMID: 21552907 DOI: 10.3892/ijo.7.4.801] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Intracerebral injection of human polyomavirus, JCV, into neonatal hamsters causes tumors of,glial origin. HJC is an established cell Line derived from a JCV-induced mixed hamster brain tumor with astrocytic and ependymal components. Flow cytometric and immunohistochemical analysis of HJC suggests that it is comprised of a mixed population of cells all of which contain the JCV early protein, T-antigen, in the nuclei. Five individual clonal lines, called HJC-15a to HJC-15e, were isolated by limiting dilution and were found to exhibit distinct morphological characteristics with 25-30% variation in their sizes. It was evident that each clone has unique growth rates, doubling times, and cell cycle parameters with different G(1), S, and G(2) phase times. All clonal cells showed the presence of the JCV early protein in the nucleus. Of interest was the observation from immunoprecipitation and Western analysis indicating qualitative and quantitative differences in the T-antigen isoforms produced in these cells. Similar to the parental clone, HJC-15b produced two distinct forms of JCV T-antigen isoforms, 88 kDa and 92 kDa proteins. In addition, HJC-15c was able to produce a 23-25 kDa protein which was recognized by anti-T-antigen antibody. The activity of cyclin-dependent kinases, in particular cdc2, was higher in HJC-15c than in the other cell lines. The data presented herein indicates that glioblastomas induced by viral T-antigen expression are composed of a multitude of distinct cells that possess a variety of different characteristics.
Collapse
Affiliation(s)
- G Raj
- THOMAS JEFFERSON UNIV,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,MOLEC NEUROVIROL SECT,PHILADELPHIA,PA 19107. THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19107
| | | | | | | | | | | | | |
Collapse
|
19
|
Raj G, Gupta G, Matthews A. Assoc Med J 2012; 345:e5859-e5859. [DOI: 10.1136/bmj.e5859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
20
|
Cost NG, Lubahn JD, Penn HA, Granberg CF, Schlomer BJ, Wickiser JE, Rakheja D, Gargollo PC, Leonard D, Baker LA, Raj G, Margulis V. Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms tumor. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.9561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
21
|
Cost NG, Delacroix SE, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp SH, Abel EJ, Brugarolas J, Raj G, Sagalowsky AI, Wood CG, Margulis V. The impact of targeted molecular therapy on the level of renal cell carcinoma (RCC) venous tumor thrombus. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e15002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
22
|
Brunetti E, Shanks RP, Manahan GG, Islam MR, Ersfeld B, Anania MP, Cipiccia S, Issac RC, Raj G, Vieux G, Welsh GH, Wiggins SM, Jaroszynski DA. Low emittance, high brilliance relativistic electron beams from a laser-plasma accelerator. Phys Rev Lett 2010; 105:215007. [PMID: 21231315 DOI: 10.1103/physrevlett.105.215007] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/31/2010] [Indexed: 05/30/2023]
Abstract
Progress in laser wakefield accelerators indicates their suitability as a driver of compact free-electron lasers (FELs). High brightness is defined by the normalized transverse emittance, which should be less than 1π mm mrad for an x-ray FEL. We report high-resolution measurements of the emittance of 125 MeV, monoenergetic beams from a wakefield accelerator. An emittance as low as 1.1±0.1π mm mrad is measured using a pepper-pot mask. This sets an upper limit on the emittance, which is comparable with conventional linear accelerators. A peak transverse brightness of 5×10¹⁵ A m⁻¹ rad⁻¹ makes it suitable for compact XUV FELs.
Collapse
Affiliation(s)
- E Brunetti
- Physics Department, University of Strathclyde, Glasgow G4 0NG, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Raj G, Legget ME, Stewart RAH, White HD, Ruygrok PN. AN EARLY INVASIVE STRATEGY IN ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROMES (ACS)—ARE WE MAKING A DIFFERENCE? Heart Lung Circ 2008. [DOI: 10.1016/j.hlc.2008.03.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Abstract
OBJECTIVE To establish rates of and risk factors for cardiac complications after noncardiac surgery in veterans. DESIGN Prospective cohort study. SETTING A large urban veterans affairs hospital. PARTICIPANTS One thousand patients with known or suspected cardiac problems undergoing 1,121 noncardiac procedures. MEASUREMENTS Patients were assessed preoperatively for important clinical variables. Postoperative evaluation was done by an assessor blinded to preoperative status with a daily physical examination, electrocardiogram, and creatine kinase with MB fraction until postoperative day 6, day of discharge, death, or reoperation (whichever occurred earliest). Serial electrocardiograms, enzymes, and chest radiographs were obtained as indicated. Severe cardiac complications included cardiac death, cardiac arrest, myocardial infarction, ventricular tachycardia, and fibrillation and pulmonary edema. Serious cardiac complications included the above, heart failure, and unstable angina. MAIN RESULTS Severe and serious complications were seen in 24% and 32% of aortic, 8.3% and 10% of carotid, 11.8% and 14.7% of peripheral vascular, 9.0% and 13.1% of intraabdominal/intrathoracic, 2.9% and 3.3% of intermediate-risk (head and neck and major orthopedic procedures), and 0.27% and 1.1% of low-risk procedures respectively. The five associated patient-specific risk factors identified by logistic regression are: myocardial infarction < 6 months (odds ratio [OR], 4.5; 95% confidence interval [CI], 1.9 to 12.9), emergency surgery (OR, 2.6; 95% CI, 1.2 to 5.6), myocardial infarction > 6 months (OR, 2.2; 95% CI, 1.4 to 3.5), heart failure ever (OR, 1.9; 95% CI, 1.2 to 3.0), and rhythm other than sinus (OR, 1.7; 95% CI, 0.9 to 3.2). Inclusion of the planned operative procedure significantly improves the predictive ability of our risk model. CONCLUSIONS Five patient-specific risk factors are associated with high risk for cardiac complications in the perioperative period of noncardiac surgery in veterans. Inclusion of the operative procedure significantly improves the predictive ability of the risk model. Overall cardiac complication rates (pretest probabilities) are established for these patients. A simple nomogram is presented for calculation of post-test probabilities by incorporating the operative procedure.
Collapse
Affiliation(s)
- R Kumar
- Received from the Section of General Internal Medicine, Department of Internal Medicine, Veterans Affairs Medical Center, U.T. Southwestern Medical School, Dallas, TX, USA.
| | | | | | | | | | | | | |
Collapse
|
25
|
Abstract
PURPOSE To determine the influence of body weight on the international normalized ratio (INR) response to a fixed dose of vitamin K in overanticoagulated patients. METHODS Retrospective review of records of patients who received 1 mg of vitamin K subcutaneously to correct excessive INR. Dose of vitamin K in milligrams per kilograms plotted against change in INR in 24 hours. RESULTS Fifteen patients were identified who met all inclusion criteria. Linear regression analysis plotted INR response at 24 hours versus dose of vitamin K adjusted for body weight. Pearson's product moment correlation (R = 0.85) indicated a significant relationship between INR response at 24 hours to an adjusted body weight dose of subcutaneous vitamin K (P = 0.0000523). A strong correlation (r = 0.69) also existed between INR response at 24 hours and the actual body weight dose of subcutaneous vitamin K (P = 0.004). CONCLUSIONS In overanticoagulated patients, variability in response to vitamin K may be explained by variability in body weight. Dosing vitamin K according to body weight may result in a more predictable INR response.
Collapse
Affiliation(s)
- K C Kelly
- Veterans Affairs North Texas Health Care System, Dallas, Texas 75216, USA.
| | | | | |
Collapse
|
26
|
Abstract
A rare case of granulocytic sarcoma of the head and neck region is presented to highlight its unusual clinical presentation and the difficulties encountered in its diagnosis. The risk factors, pathological findings, and treatment modalities are discussed to make head and neck surgeons aware of this condition, which can have a fatal outcome as happened in our case.
Collapse
Affiliation(s)
- D R Nayak
- Department of Ear, Nose, Throat and Head & Neck Surgery, Kasturba Medical College, Manipal, India
| | | | | | | | | | | |
Collapse
|
27
|
Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med 1999; 159:2721-4. [PMID: 10597763 DOI: 10.1001/archinte.159.22.2721] [Citation(s) in RCA: 103] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
BACKGROUND Excessive anticoagulation increases the risk of hemorrhagic complications associated with oral anticoagulant therapy. Oral or parenteral phytonadione is used to reverse excessive anticoagulation. Intravenous (IV) phytonadione, while effective, is associated with a small risk of serious anaphylactic reactions. Subcutaneous (SC) administration is safer, but there is little information on its relative efficacy in small doses. METHODS Twenty-two patients with asymptomatic prolongation of prothrombin time were prospectively randomized and treated with 1 mg of phytonadione IV or 1 mg SC. Prothrombin time was measured at baseline and at 8 and 24 hours after phytonadione administration and expressed as international normalized ratio (INR). RESULTS Mean INR at baseline was 8.0 and 8.5 in the IV and SC groups, respectively (P = .70). At 8 hours, mean INR was 4.6 in the IV group and 8.0 in the SC group (P = .006), and at 24 hours, mean INR was 3.1 in the IV group and 5.0 in the SC group (P = .009). Mean decrease in INR 8 hours after administration of phytonadione was 3.4 in the IV group and 0.4 in the SC group (P = .02), and mean decrease in INR after 24 hours was 4.9 in the IV group and 3.4 in the SC group (P = .18). CONCLUSIONS For patients who are excessively anticoagulated with warfarin, small doses of SC phytonadione may not correct the INR as rapidly or as effectively as when administered IV. Higher doses must be considered for more rapid and complete reversal of anticoagulation by the SC route.
Collapse
Affiliation(s)
- G Raj
- Section of General Internal Medicine, Dallas Veterans Affairs Medical Center, and Department of Medicine, University of Texas Southwestern Medical Center, 75216, USA.
| | | | | |
Collapse
|
28
|
|
29
|
Raj G, Kumar R, McKinney WP. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy. Arch Intern Med 1995; 155:1529-31. [PMID: 7605155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
BACKGROUND The effect of influenza vaccine on the prothrombin time (PT) among patients taking warfarin is unclear, as previous studies have shown conflicting results and the clinical significance of such a purported effect is uncertain. Moreover, to our knowledge, there are no data confirming the safety of intramuscular injections in patients receiving anticoagulant therapy with regard to possible local hematoma formation. We measured the effect of influenza vaccine on the PT among patients receiving long-term warfarin sodium therapy and evaluated the safety of intramuscular injections among them. METHODS Forty-one adult patients who were receiving anticoagulant therapy were given 0.5 mL of influenza vaccine intramuscularly. Prothrombin time and arm girth were measured at baseline and on days 3, 7, and 14 after immunization. Local pain and tenderness were assessed on a five-point scale. Patients and study nurses were blinded to all prior measurements. Differences between baseline PT and that at each subsequent visit and the maximal change in arm circumference from baseline were calculated for each patient. Mean, range, and 95% confidence intervals were calculated for the entire group. RESULTS There was no statistically significant change in PT between baseline and days 3, 7, and 14 after vaccination, and no significant change in arm circumference was noted. There were no clinically detectable local complications after intramuscular injection and no major or minor bleeding episodes after influenza vaccination. CONCLUSIONS Influenza vaccine has no significant effect on the PT in patients who are being treated with warfarin. Influenza vaccine can be administered intramuscularly to patients who are receiving anticoagulant therapy without the risk of local bleeding complications.
Collapse
Affiliation(s)
- G Raj
- Section of General Internal Medicine, Veterans Affairs Medical Center, Dallas, USA
| | | | | |
Collapse
|
30
|
Abstract
Acid precipitated and detergent treated Newcastle disease virus (NDV) antigen was prepared and characterised using the agar gel precipitation (AGP) test. The detergent treated NDV antigen was used to screen antibodies to NDV and the results compared with the conventional haemagglutination inhibition (HI) test titres. AGP test could detect NDV antibodies in serum samples when the corresponding HI titres were 1:8 and above. Detergent treatment of Newcastle disease virus greatly reduced its haemagglutinating ability. Simultaneous detection of antibodies to NDV and infectious bursal disease virus in AGP test was attempted and found successful.
Collapse
Affiliation(s)
- G Raj
- Centre for Animal Health Studies, Madras, India
| | | | | | | | | |
Collapse
|
31
|
Kerr D, Chang CF, Chen N, Gallia G, Raj G, Schwartz B, Khalili K. Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 1994; 68:7637-43. [PMID: 7933155 PMCID: PMC237216 DOI: 10.1128/jvi.68.11.7637-7643.1994] [Citation(s) in RCA: 47] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
We have isolated a partial recombinant cDNA clone from a HeLa expression library which encodes a protein capable of binding to the central region of the human neurotropic JC virus (JCV) enhancer/promoter, termed the B region. Sequence analysis revealed a complete homology of the partial cDNA clone to the N-terminal region, of a previously described DNA-binding protein, termed YB-1. Band shift analyses have indicated that the bacterially produced YB-1 interacts specifically with the double-stranded B oligonucleotide as well as the corresponding single-stranded DNA fragment representing the early promoter sequence. Further analysis indicated that the YB-1 protein binds specifically to the C/T-rich sequence of the B domain, which is located in close proximity to the TATA box within the virus enhancer/promoter. Results from cotransfection experiments demonstrated that the full-length (YB-1) but not the partial cDNA enhances expression of the JCV late (JCVL) promoter in glial cells. Cointroduction into glial cells of a recombinant expressing the YB-1 and JCVL deletion mutants indicated that removal of the C/T-rich sequence of the B domain reduces the level of activation of the virus promoter by YB-1. Further cotransfection experiments revealed that the virus transactivating protein T antigen appears to diminish the ability of YB-1 to activate JCVL gene expression. RNA studies indicated that YB-1 is expressed in several cell types and tissues. Examination of YB-1 RNA from mouse brain at various stages of development revealed high levels of YB-1 RNA at early stages of development and lower levels at all subsequent developmental stages.
Collapse
Affiliation(s)
- D Kerr
- Jefferson Institute of Molecular Medicine, Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
| | | | | | | | | | | | | |
Collapse
|
32
|
Abstract
Late infantile neuronal lipofuscinosis was confirmed by electron microscopy in this case. At magnifications above 100,000 a particular alternating linear pattern of the curvilinear bodies was found.
Collapse
Affiliation(s)
- L Buhl
- Department of Pathology, Sultan Qaboos University Hospital, Oman
| | | | | | | |
Collapse
|
33
|
Abstract
Oral anticoagulant therapy is used extensively in the treatment of deep venous thrombosis-pulmonary embolism and prevention of systemic thromboembolism. Adoption of the International Normalized Ratio system for the laboratory monitoring of therapy has solved the problems encountered with the variable sensitivities of the available thromboplastins in North America. Although in recent years the recommended intensity of treatment has been reduced for many indications, bleeding remains the most common side effect of long-term oral anticoagulation therapy. Several drugs interact with warfarin sodium, the most commonly used oral anticoagulant drug, and potentiate its effect, thereby increasing the risk of bleeding. However, awareness of potential drug interactions and careful monitoring to maintain patients within the recommended therapeutic ranges can minimize the risk of bleeding and lead to its safe use in most patients.
Collapse
Affiliation(s)
- G Raj
- Medical Service (111), Department of Veterans Affairs Medical Center, Dallas, TX 75216
| | | | | |
Collapse
|
34
|
Abstract
Venous thromboembolism is an important cause of morbidity and mortality in hospitalized patients, causing 100,000 to 200,000 deaths per year in the United States. Patients undergoing surgery are at the highest risk of venous thromboembolism. The magnitude of this risk in a patient depends on the surgical procedure performed and the presence of other risk factors that predispose to venous thromboembolism. The clinical diagnosis of both deep vein thrombosis and pulmonary embolism is notoriously inaccurate. Furthermore, two thirds of all fatal pulmonary emboli cause death within 30 minutes of the embolic episode, leaving little time for diagnostic work-up and effective treatment. Prophylactic treatment for prevention of venous thromboembolism is therefore important in these patients, and several effective mechanical and chemical methods for this purpose are available. The pathogenesis of deep vein thrombosis in the surgical patients, the predisposing risk factors, and the available prophylactic modalities are discussed in this article. Recommendations for the use of various approaches in different risk categories are provided.
Collapse
Affiliation(s)
- R Kumar
- Section of General Internal Medicine, Department of Veterans Affairs Medical Center, Dallas, Texas 75216
| | | | | |
Collapse
|